NLRC5 and breast adenocarcinoma: Among these cell lines, A549 (lung carcinoma), MCF7 (mammary adenocarcinoma) and T47D (mammary ductal carcinoma) were selected for low NLRC5 expression and varying levels of HLA expression (Supplementary Figure S2B).